Alpha Family Trust’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$395K Hold
750
– – 0.16% 102
2026
Q1
$421K Hold
750
– – 0.2% 85
2025
Q4
$507K Hold
750
– – 0.23% 72
2025
Q3
$479K Hold
750
– – 0.22% 79
2025
Q2
$402K Hold
750
– – 0.2% 96
2025
Q1
$315K Buy
750
+75
+11% +$32.6K 0.18% 113
2024
Q4
$279K Buy
675
+215
+47% +$94.3K 0.16% 110
2024
Q3
$232K Hold
460
– – 0.13% 140
2024
Q2
$224K Hold
460
– – 0.13% 133
2024
Q1
$248K Hold
460
– – 0.15% 126
2023
Q4
$255K Hold
460
– – 0.17% 115
2023
Q3
$201K Hold
460
– – 0.15% 123
2023
Q2
$231K Hold
460
– – 0.16% 107
2023
Q1
$230K Buy
+460
New +$220K 0.18% 107

Other funds holding IDXX

Alpha Family Trust's IDXX Position: Q2 2026 in Review

Alpha Family Trust held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 750 shares worth $395K. The position accounts for 0.16% of the portfolio, ranked #102.

Alpha Family Trust first reported a position in IDXX in Q1 2023 and has held it in 14 quarters since. The position peaked at $507K in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Alpha Family Trust held 750 shares of Idexx Laboratories worth $395K as of Q2 2026.
  • Alpha Family Trust left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.16% of Alpha Family Trust's portfolio in Q2 2026, its #102 holding.
  • Alpha Family Trust first reported a position in Idexx Laboratories in Q1 2023 and has held it in 14 quarters since.
  • Alpha Family Trust's Idexx Laboratories position peaked at $507K in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Alpha Family Trust's 13F filing for Q2 2026, filed 10 Aug 2026.